Lisinopril for Polycythemia

This trial tests whether lisinopril, a medication typically used to lower blood pressure, can help people with secondary polycythemia. In this condition, the body produces too many red blood cells due to certain genetic changes or other unexplained reasons. The study aims to determine if lisinopril can reduce these cells by affecting a hormone called erythropoietin. Suitable candidates for this trial have high hemoglobin levels and no history of smoking or specific blood and respiratory problems. As a Phase 4 trial, lisinopril is already FDA-approved and proven effective, and this research seeks to understand how it benefits more patients.

You will need to stop taking ACE inhibitors, potassium-sparing diuretics, and SGLT2 medications if you are currently using them. The trial does not specify other medications, so it's best to discuss with the trial team.

Research has shown that lisinopril, an ACE inhibitor, is generally safe for people. It often treats high blood pressure and some altitude-related issues. Studies have found that ACE inhibitors like lisinopril can safely address blood-related problems. Previous human trials have already tested lisinopril, indicating its safety. While mild side effects like dizziness or a cough may occur, serious issues are rare. Consulting a doctor is always advisable if there are any concerns.¹²³⁴⁵

Lisinopril is unique because it offers a different approach to managing polycythemia. Unlike the standard treatments, which often involve phlebotomy or medications like hydroxyurea to reduce red blood cell counts, lisinopril is an angiotensin-converting enzyme (ACE) inhibitor. Researchers are excited because it could potentially regulate blood pressure and improve circulation, offering a dual benefit for patients. This new mechanism of action might provide a safer and potentially more effective option for those who struggle with traditional treatments.

Research has shown that lisinopril, a type of medication, can help reduce the overproduction of red blood cells in some forms of polycythemia. This trial will treat participants with lisinopril to assess its effectiveness. Studies have found that medications like lisinopril can lower the percentage of red blood cells in the blood. In some cases, lisinopril significantly reduces both the red blood cell count and the levels of erythropoietin, a hormone that encourages red blood cell production. This suggests that lisinopril may help manage high red blood cell counts by decreasing the activity of this hormone.¹²³⁴⁶